During the past decade, Austin Health (Ludwig Institute Oncology Unit) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Health (Ludwig Institute Oncology Unit)" #1 collaborator was "Austin Health" with 1 trials as a collaborator, "Heidelberg Pharma AG" with 1 trials as a collaborator, "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator, "Peter MacCallum Cancer Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Austin Health (Ludwig Institute Oncology Unit)" are "Melanoma" (2 trials) and "Renal Cell Carcinoma (RCC)" (1 trials). Many other conditions were trialed in "Austin Health (Ludwig Institute Oncology Unit)" in a lesser frequency.

Most popular intervention types in "Austin Health (Ludwig Institute Oncology Unit)" are "Biological" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Chimeric monoclonal antibody cG250" (1 trials), "Cyclophosphamide" (1 trials), "ISCOMATRIX® adjuvant" (1 trials), "NY-ESO-1 ISCOMATRIX®" (1 trials) and "NY-ESO-1 ISCOMATRIX® vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Austin Health (Ludwig Institute Oncology Unit)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Austin Health (Ludwig Institute Oncology Unit)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Austin Health (Ludwig Institute Oncology Unit), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Health (Ludwig Institute Oncology Unit), 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".